Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1177-1182

  Mori, Masaki ^b   Mimori, Koshi ^a   Shiraishi, Takeshi ^b   Alder, Hansjuerg ^a   Inoue, Hiroshi ^b   Tanaka, Yoichi ^c   Sugimachi, Keizo ^d   Huebner, Kay ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME DELETION; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; AGED; CARCINOMA; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROTEIN BIOSYNTHESIS; PROTEINS;

EID: 0034161988     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Obta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa. R., Palazzo, J., Siprashvili, Z., Mon, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
2. Barnes, L. D., Garrison, P. N., Siprashvili, Z., Guranowski, A., Robinson, A. K., Ingram, S. W., Croce, C. M., Ohta, M., and Huebner, K. FHIT. a putative tumor suppressor in humans, is a dinucleoside 5′5‴-P-1. P-3-triphosphate hydrolase. Biochemistry, 36: 11529-11535, 1996.
3. Croce, C. M., Sozzi, G., and Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol., 17: 1618-1624, 1999.
4. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanisms of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
5. Mimori, K., Druck, T., lnoue, H., Alder, H., Berk, L., Mori, M., Huebner, K., and Croce, C. M. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc. Natl Acad. Sci. USA, 96: 7456-7461, 1999.
6. Michael, D., Beer, D. G., Wilke, C. W., Miller, D. E., and Glover, T. W. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Oncogene, 15, 1653-1659, 1997.
7. Zou, T. T., Lei, J., Shi, Y. Q., Yin, J., Wang, S., Souza, R. F., Kong, D., Shimada, Y., Smolinski, K. M., Greenwald, B. D., Abraham, J. M., Harpaz, N., and Meltzer, S. J. FHIT gene alterations in esophageal cancer and ulceralive colitis (UC). Oncogene, 15: 101-105, 1997.
8. Nelson, H. N., Wiencke, J. K., Gunn, L., Wain, J. C., Christiani, D. C., and Kelsey, K. T. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res., 58: 1804-1807, 1998
9. Morita, M., Kuwano, H., Ohno, S., Sugimachi, K., Seo, Y., Tomoda, H., Furusawa, M., and Nakashima, T. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int. J. Cancer, 58: 207-210, 1994.
10. Sozzi, G., Pastorino, U., Moiraghi, L., Tagliabue, E., Pezzella, F. Ghirelli, C., Tomielli, S., Sard, L., Huebner, K., Pierotti, M. A., Croce, C. M., and Pilotti, S. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res., 58: 5032-5037, 1998.
11. Mori, M., Barnard, G. F., Staniunas, R. J., Jessup, J. M., Steele, G. D., Jr., and Chen, L. B. Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 8: 2821-2826, 1993.
12. Mori, M., Shiraishi, T., Tanaka, S., Yamagata, M., Mafune, K., Tanaka, Y., Ueo, H., Barnard, G. F., and Sugimachi, K. Lack of DMBTI expression in oesophageal, gastric and colon cancer. Br. J. Cancer, 79: 211-213, 1999.
13. Ishii, H., Baffa, R., Numata, S., Murakumo, Y., Rattan, S., Inoue, H., Mori, M., Fidanza, V., Alder, H., and Croce, C. M. The FEZI gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc. Natl. Acad. Sci. USA, 96: 3928-3933, 1999.
14. Campiglio, M., Pekarsky, Y., Menard, S., Tagliabue, E., Pilotti, S., and Croce, C. M. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res., 59: 3866-3869, 1999.
15. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
16. Hadaczek, P., Siprashvili, Z., Markiewski, M., Domagala, W., Druck, T., McCue, P. A., Pekarsky, Y., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of FHIT expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.
17. Baffa, R., Veronese, M. L., Santoro, R., Mandes, B., Palazzo, J. P., Rugge, M., Sanloro, E., Croce, C. M., Huebner, K. Loss of FHIT expression in gastric carcinoma. Cancer Res., 58: 4708-4714, 1998.
18. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue. E., Greco, A., Fusetti, L., Schwanz, G., Pierotli, M. A., Croce, C. M., and Huebner, K. Replacement of FHITm cancer cells suppress tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
19. Enterline, H., and Thompson, J. Squamous cell carcinoma. In: Pathology of the Esophagus, pp. 145-164. New York: Springer, 1984.
20. Sorio, C., Baron, A., Orlandini, S., Zamboni, G., Pederzoli, P., Huebner, K., and Scarpa, A. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res., 59; 1308-1314, 1999.
21. Wistuba, I. I., Lam, S., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Sarnet, J. M., Srivastava, S., Minna, J. D., and Gazdar, A. D. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst., 89: 1366-1373, 1997.
22. Baffa, R., Cornelia, L. G., Vecchione, A., Bassi, P., Sedor, J., Calviello, C., Gardiman, M., Minimo, C., Strap, S. E., McCue, P. A., Kovatich, A., Pagano, F., Huebner, K., and Croce, C. M. Loss of Fhit expression in transitional cell carcinoma (TCC) of the urinary bladder. Amer. J. Pathol., 156: 419-424, 2000.
23. Sard, L. Accornero, P., Tornielli, S., Delia, D., Bunone, G., Campiglio, M., Colombo, M. P., Gramegna, M., Croce, C. M., Pierotti, M. A., and Sozzi, G. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Natl. Acad. Sci. USA, 96: 8489-8492, 1999.
24. Sugimachi, K. Advances in the surgical treatment of oesophageal cancer. Br. J. Surg., 85: 289-290, 1998.